title: Isolation of pi-alcohol dehydrogenase of human liver: is it a determinant of alcoholism?
abstract: HUMAN LIVER ALCOHOL DEHYDROGENASE (ALCOHOL: NAD(+) oxidoreductase, EC 1.1.1.1), homogeneous by physicochemical criteria, has been available in quantity only recently [Lange, L. G. & Vallee, B. L. (1976) Biochemistry 15, 4681-4686]. Until now, the biochemical basis of human alcohol metabolism had to be extrapolated from the properties and behavior of enzymes from other species, primarily horses and yeast. The biological determinants of human alcoholism have remained obscure, although recent evidence indicates a genetic predisposition, requiring delineation. A functionally distinct form of human liver alcohol dehydrogenase (ADH), which we have designated II-ADH, is provocative since, thus far, it seems to be unique to human beings. It has a high K(m) for ethanol and is remarkably insensitive (apparent K(I), 500 muM) to pyrazole and its derivatives, which are usually potent ADH inhibitors (K(I), 1 muM), a property that is the basis for the isolation of II-ADH. The affinity resin 4-[3-(N-6-aminocaproyl)aminopropyl]pyrazole-Sepharose binds all other known forms of ADH but not II-ADH, thereby separating it selectively by affinity chromatography. In turn, this has led to the establishment of its identity with that enzyme form which was previously known as the anodic band and characterized by a high K(m) for ethanol (20 mM at pH 7.5). The remarkable insensitivity of II-ADH to pyrazole inhibition has also permitted quantitation of its role in hepatic ethanol oxidation. At 5 mM ethanol, a saturating concentration for virtually all other forms of ADH, II-ADH contributes less than 15% to total ethanol oxidation. However, at intoxicating concentrations, e.g., 60 mM, it can account for as much as 40% of the total ethanol oxidation rate of liver, indicating a seemingly unique role for this enzyme form in ethanol elimination. Thus far, we have found the amount of II-ADH varies from liver to liver of individuals and is considerably more labile than the other molecular forms, phenomena whose inter- or independence requires further study. The isolation of human II-ADH advances efforts to recognize and understand biochemical mechanisms that may be biological determinants of alcoholism and alcohol-related disease states, now generally approached and managed largely as psychosocial disorders.
mesh_terms: D000429:Alcohol Oxidoreductases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000302:isolation & purification*; D000437:Alcoholism / Q000201:enzymology* / Q000235:genetics; D006801:Humans; D066298:In Vitro Techniques; D008099:Liver / Q000201:enzymology*; D011720:Pyrazoles / Q000494:pharmacology
chemical_list: D011720:Pyrazoles; D000429:Alcohol Oxidoreductases
references.citation: Biochemistry. 1976 Oct 19;15(21):4681-6
references.pmid: 9981
references.citation: Biochemistry. 1976 Oct 19;15(21):4687-93
references.pmid: 9982
references.citation: Biochem Pharmacol. 1975 Sep 1;24(17):1603-7
references.pmid: 172084
references.citation: Adv Enzymol Relat Areas Mol Biol. 1977;45:427-83
references.pmid: 335822
references.citation: Biochem Biophys Res Commun. 1977 Jan 10;74(1):85-91
references.pmid: 836289
references.citation: Biochem Biophys Res Commun. 1975 Mar 3;63(1):202-8
references.pmid: 1125010
references.citation: N Engl J Med. 1976 Jan 1;294(1):9-13
references.pmid: 1244489
references.citation: Biochem Pharmacol. 1969 Jul;18(7):1749-62
references.pmid: 4308803
references.citation: Acta Chem Scand. 1969;23(3):892-902
references.pmid: 4308830
references.citation: Gastroenterology. 1971 Nov;61(5):707-15
references.pmid: 4399030
references.citation: Pharmacol Rev. 1972 Mar;24(1):67-157
references.pmid: 4402043
references.citation: J Pharmacol Exp Ther. 1972 May;181(2):279-87
references.pmid: 4402282
references.citation: Eur J Biochem. 1972 Feb;25(3):420-30
references.pmid: 4402915
references.citation: Arch Biochem Biophys. 1972 Nov;153(1):279-93
references.pmid: 4405525
references.citation: Ann Hum Genet. 1974 Jul;38(1):31-7
references.pmid: 4460862
references.citation: Arch Gen Psychiatry. 1974 Aug;31(2):164-9
references.pmid: 4851437
references.citation: Can J Biochem. 1965 Jul;43(7):889-98
references.pmid: 4955112
references.citation: Ann Hum Genet. 1972 Mar;35(3):243-53
references.pmid: 5072686
references.citation: Clin Pharmacol Ther. 1971 Mar-Apr;12(2):192-201
references.pmid: 5102974
references.citation: Am J Med. 1971 Sep;51(3):346-51
references.pmid: 5115992
references.citation: Eur J Biochem. 1971 Dec;24(2):271-9
references.pmid: 5157297
references.citation: Life Sci II. 1970 Jun 8;9(11):631-40
references.pmid: 5478078
references.citation: Ann Hum Genet. 1971 Feb;34(3):251-71
references.pmid: 5548434
references.citation: Biochemistry. 1966 Jun;5(6):2026-34
references.pmid: 5963446
references.citation: Acta Pharmacol Toxicol (Copenh). 1958;14(3):265-89
references.pmid: 13532737
references.citation: Biochemistry. 1964 Nov;3:1775-82
references.pmid: 14235347
references.citation: J Clin Invest. 1965 May;44:817-30
references.pmid: 14276139
references.citation: Q J Stud Alcohol. 1955 Mar;16(1):1-33
references.pmid: 14372008
references.citation: Science. 1949 Jun 10;109(2841):594-5
references.pmid: 17835387